Deep Brain Stimulation in Moroccan Patients With Parkinson's Disease: The Experience of Neurology Department of Rabat
Authors:
Open Access
- 31 July 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 9, 532
Abstract
Introduction: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is known as a therapy of choice of advanced Parkinson's disease. The present study aimed to assess the beneficial and side effects of STN DBS in Moroccan Parkinsonian patients. Material and Methods: Thirty five patients underwent bilateral STN DBS from 2008 to 2016 in the Rabat University Hospital. Patients were assessed preoperatively and followed up for 6 to 12 months using the Unified Parkinson's Disease Rating Scale in four conditions (stimulation OFF and ON and medication OFF and ON), the levodopa-equivalent daily dose (LEDD), dyskinesia and fluctuation scores and PDQ39 scale for quality of life (QOL). Postoperative side effects were also recorded. Results: The mean age at disease onset was 42.31 ± 7.29 years [28–58] and the mean age at surgery was 54.66 ± 8.51 years [34–70]. The median disease duration was 11.95 ± 4.28 years [5–22]. Sixty-three percentage of patients were male. 11.4% of patients were tremor dominant while 45.71 showed akinetic-rigid form and 42.90 were classified as mixed phenotype. The LEDD before surgery was 1200 mg/day [800-1500]. All patients had motor fluctuations whereas non-motor fluctuations were present in 61.80% of cases. STN DBS decreased the LEDD by 51.72%, as the mean LEDD post-surgery was 450 [188-800]. The UPDRS-III was improved by 52.27%, dyskinesia score by 66.70% and motor fluctuations by 50%, whereas QOL improved by 27.12%. Post-operative side effects were hypophonia (2 cases), infection (3 cases), and pneumocephalus (2 cases). Conclusion: Our results showed that STN DBS is an effective treatment in Moroccan Parkinsonian patients leading to a major improvement of the most disabling symptoms (dyskinesia, motor fluctuation) and a better QOL.Keywords
This publication has 96 references indexed in Scilit:
- Effects of STN and GPi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation SyndromePLOS ONE, 2012
- Impulse control disorders in Parkinson's diseaseCurrent Opinion in Neurology, 2011
- Deep-brain stimulation for basal ganglia disordersBasal Ganglia, 2011
- Effects of subthalamic stimulation on speech of consecutive patients with Parkinson diseaseNeurology, 2011
- Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPiActa Neurochirurgica, 2010
- Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trialThe Lancet Neurology, 2010
- Surgical, Medical, and Hardware Adverse Events in a Series of 141 Patients Undergoing Subthalamic Deep Brain Stimulation for Parkinson DiseaseWorld Neurosurgery, 2010
- Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson’s disease. Review of 272 proceduresActa Neurochirurgica, 2007
- Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery--experiences from a single centreJournal of Neurology, Neurosurgery & Psychiatry, 2006
- The development and validation of a short measure of functioning and well being for individuals with Parkinson's diseaseQuality of Life Research, 1995